UK markets closed

Oxford BioDynamics Plc (OBD.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
20.25+0.10 (+0.50%)
At close: 05:03PM GMT

Oxford BioDynamics Plc

3140 Rowan Place
John Smith Drive Oxford Business Park South
Oxford OX4 2WB
United Kingdom
44 1865 518 910

Full-time employees44

Key executives

NameTitlePayExercisedYear born
Dr. Jon Anthony Joseph Burrows B.Sc., M.Sc., Ph.D.CEO & Director463kN/A1963
Mr. Paul Leslie Stockdale F.C.A., M.A.CFO & Director202kN/A1975
Dr. Alexandre Akoulitchev Ma (Oxon), Ph.D.Chief Scientific Officer & Director236kN/A1962
Mr. Thomas G. Guiel B.A.Chief Operating OfficerN/AN/AN/A
Dr. Jayne Green B.Sc., Ph.D.Director of OperationsN/AN/AN/A
Dr. Ewan Hunter B.Sc., BSC, Ph.D., Ph.D., (KCL)C.D.ON/AN/AN/A
T. DemainCompany Sec.N/AN/AN/A
Dr. Steven Tucker M.D., FACPGroup Clinical DirectorN/AN/AN/A
Prof. Siamon GordonClinical Director of Inflammation & InfectionN/AN/AN/A
Dr. Sandy Primrose Ph.D.Technical ConsultantN/AN/AN/A
Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in GBp.


Oxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and internationally. The company provides EpiSwitch, a proprietary technology platform for the discovery, evaluation, validation, and monitoring of epigenetic biomarkers known as chromosome conformation signatures for use in medical testing kits, disease prediction, diagnosis, and treatment. Its products include EpiSwitch CiRT (Checkpoint Inhibitor Response Test), a validated prognostic test for predicting response to checkpoint inhibitor immunotherapy; EpiSwitch CST (Covid Severity Test), an advanced blood test for the prediction of COVID-19 severity in adults; and EpiSwitch Explorer Array Kit for high-resolution 3D genome profiling and biomarker discovery. Oxford BioDynamics Plc was incorporated in 2007 and is headquartered in Oxford, the United Kingdom.

Corporate governance

Oxford BioDynamics Plc’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.